Molecular Diagnostics Market
Molecular Diagnostics Market - Global Industry Assessment & Forecast
#
Pages:
141
2022
Sep - 2024
VMR-2338
Segments Covered
By
Product & Service Reagents & Kits, Instruments, Services & Software
-
By
Test Type Lab Tests, PoC Tests
-
By
Sample Type Blood, Serum, & Plasma, Urine, Other Sample Types
-
By
Technology Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-generation Sequencing, In Situ Hybridization, DNA Microarrays, Other Technologies
-
By
Application Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, COVID-19, Other Applications
-
By
End User Diagnostic Laboratories, Hospitals & Clinics, Other End Users
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 14.9 Billion |
 Revenue 2030:
|
USD 35.8 Billion |
 Revenue CAGR
(2023 - 2030): |
11.6% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2017 to 2021 |
| 3. | Forecast Data | 2023 to 2030 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 22-Nov-2023
FAQ
Frequently Asked Question
What is the global demand for Molecular Diagnostics in terms of revenue?
-
The global Molecular Diagnostics valued at USD 14.9 Billion in 2022 and is expected to reach USD 35.8 Billion in 2030 growing at a CAGR of 11.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Becton Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies Inc. (U.S.), Danaher Corp. (U.S.), Hologic Inc. (U.S.), Illumina Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Grifols S.A. (Spain), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Sysmex Corporation (Japan).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 11.6% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Molecular Diagnostics include
- Introduction of technologically advanced products
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Molecular Diagnostics in 2022.
